In conclusion, our findings indicate that promoter hypomethylation of the PDZK1 promoter was the reason for the high expression of PDZK1 in glioma, and the methylation level of PDZK1 is a meaningful prognostic marker in glioma. Here, PDZK1 is linked to glioma.